FDA — authorised 10 December 1979
- Application: NDA018063
- Marketing authorisation holder: USWM
- Local brand name: CORGARD
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 Corgard in United States
FDA authorised Corgard on 10 December 1979
Marketing authorisations
FDA — authorised 10 December 1979
- Marketing authorisation holder: KING PHARMS
- Status: approved
FDA — authorised 31 October 1993
- Application: ANDA074172
- Marketing authorisation holder: RISING
- Local brand name: NADOLOL
- Indication: TABLET — ORAL
- Status: approved
FDA — authorised 31 August 1994
- Application: ANDA074368
- Marketing authorisation holder: TEVA PHARMS
- Local brand name: NADOLOL
- Indication: TABLET — ORAL
- Status: approved
FDA — authorised 9 November 1995
- Application: ANDA074501
- Marketing authorisation holder: SANDOZ
- Local brand name: NADOLOL
- Indication: TABLET — ORAL
- Status: approved
FDA — authorised 24 January 1996
- Application: ANDA074255
- Marketing authorisation holder: HERITAGE PHARMA
- Local brand name: NADOLOL
- Indication: TABLET — ORAL
- Status: approved
FDA — authorised 30 August 1996
- Application: ANDA074229
- Marketing authorisation holder: HERITAGE PHARMA
- Local brand name: NADOLOL
- Indication: TABLET — ORAL
- Status: approved
FDA — authorised 5 October 2017
- Application: ANDA209309
- Marketing authorisation holder: CHARTWELL RX
- Local brand name: NADOLOL
- Indication: TABLET — ORAL
- Status: approved
FDA — authorised 1 June 2018
- Application: ANDA210786
- Marketing authorisation holder: NOVAST LABS
- Local brand name: NADOLOL
- Indication: TABLET — ORAL
- Status: approved
FDA — authorised 13 September 2019
- Application: ANDA212856
- Marketing authorisation holder: RK PHARMA
- Local brand name: NADOLOL
- Indication: TABLET — ORAL
- Status: approved
FDA — authorised 2 June 2023
- Application: ANDA211763
- Marketing authorisation holder: ALEMBIC
- Local brand name: NADOLOL
- Indication: TABLET — ORAL
- Status: approved
Corgard in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in United States
Frequently asked questions
Is Corgard approved in United States?
Yes. FDA authorised it on 10 December 1979; FDA authorised it on 10 December 1979; FDA authorised it on 31 October 1993.
Who is the marketing authorisation holder for Corgard in United States?
USWM holds the US marketing authorisation.